Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Shanghai SIMR Biotech synthesizes new PLA2G7 inhibitors

June 1, 2021

Chinese investigators disclose new componds for schizophrenia

May 31, 2021

Gene therapy can address infantile Parkinson's

May 31, 2021

DSMB recommends continuation of uniQure's phase I/II trial of AMT-130 in Huntington's disease

May 28, 2021

China NMPA approves CTA for phase IIb trial of AM-006 in Parkinson's disease

May 28, 2021

Gene signature governs anti-plaque microglia in AD

May 28, 2021

New opioid receptor agonists identified at Fudan University

May 27, 2021

FDA clears IND for phase I/II study of LION-101 gene therapy as treatment of LGMD2I/R9

May 27, 2021

FDA places clinical hold on Larimar's CTI-1601 for Friedreich's ataxia

May 26, 2021

Nasally administered foralumab studied in secondary progressive multiple sclerosis

May 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...